Latest Industry Updates
From company milestones to industry breakthroughs, uncover the stories making waves and shaping the narrative in real time.
- Featured Article
In part 2 of this video interview series, Ken Getz, executive director and research professor, Tufts...
Source: Applied Clinical Trials
- Featured Article
In part 1 of this video interview series with Ken Getz, executive director and research professor,...
Source: Applied Clinical Trials
- Featured Article
We are at a tipping point in the adoption of Clinical Research 2.0. The evolution of...
Source: PM360
- Press Release
King of Prussia, PA – March 25, 2024: CluePoints, providers of best-in-class statistical and AI-driven software...
- Press Release
King of Prussia, PA: A comprehensive assessment of risk-based quality management (RBQM) adoption has revealed that...
- Press Release
King of Prussia, PA – March 5, 2024: CluePoints, providers of best-in-class statistical and AI-driven software...
- Featured Article
In an interview with ACT editor Andy Studna at SCOPE, Young, Chief Science Officer, CluePoints discusses...
Source: Applied Clinical Trials
- Featured Article
Central monitoring aims at improving the quality of clinical research by pro-actively identifying risks and remediating...
Source: Springer Link
- Press Release
King of Prussia, PA – February 6, 2024: CluePoints, providers of best-in-class statistical and AI-driven software...
- Featured Article
We spoke with leaders and experts in the Clinical Research community about their predictions for 2024.
...Source: Clinical Research News
- Featured Article
Key risk indicators (KRIs) are commonly used as an important component of central monitoring to enable...
Source: Applied Clinical Trials
- Featured Article
Central monitoring helps sponsors to proactively identify and remediate data quality issues during the conduct of...
Source: Applied Clinical Trials
- Press Release
On July 28, CluePoints is teaming up with DIA for a webinar to explore how the...
- Press Release
Personalizing the Power of Statistical Analysis and Data Visualization King of Prussia, PA: CluePoints, the premier...
- Press Release
RISK MANAGEMENT SOLUTION ADDRESSES FDA, EMA, PMDA & MHRA CORONAVIRUS ADVICE King of Prussia, PA: CluePoints,...
- Press Release
King of Prussia, PA: CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Data Quality...
- Press Release
Risk Planning Guidance Addresses FDA, EMA, PMDA and MHRA Coronavirus Advice King of Prussia, PA: CluePoints,...
- Press Release
We’re delighted to announce that the recording for our COVID-19 webinar has been posted! About the...
- Press Release
Remote monitoring is mitigating the impact of SARS-CoV-2 on clinical trials, marking an acceleration in the...
- Press Release
King of Prussia, PA: CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Risk-Based Quality...
- Press Release
KING OF PRUSSIA, PA: CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Data Quality...
- Press Release
KING OF PRUSSIA, PA– FDA and its stakeholders have an interest in assuring the integrity of...
- Press Release
“I KNOW ICH E6 (R2) COMPLIANCE INSISTS ON A RISK-BASED APPROACH TO RUNNING MY TRIALS, BUT...
- Press Release
Strategic collaboration leverages CluePoints’ Central Statistical Monitoring (CSM) technology to enhance data quality and reduce operational...
- Featured Article
As a follow-up to Clinical Trials Day 2025, held on May 20 with the theme of...
Source: The Association of Clinical Research Professionals
- Featured Article
“Identifying … potential data manipulation and data integrity problems” are an International Council for Harmonization of...
Source: Applied Clinical Trials
- Featured Article
Artificial Intelligence (AI) continues to gain momentum in the pharmaceutical sector, but can it truly deliver...
Source: Health Tech World
- Featured Article
Dr Laura Trotta gives us an insight into her role at CluePoints and shares some of...
Source: Health Tech World
- Featured Article
Sas Maheswaran discusses how artificial intelligence, data and strategic partnerships can make clinical trials more sustainable...
Source: ONdrugDelivery
- Featured Article
Andrew Cooper, CEO, CluePoints, explores how AI is transforming clinical trials, the power of a purpose-driven...
Source: European Medical Journal GOLD
- Featured Article
The monitoring of key risk indicators (KRIs) is an established form of risk control in the...
Source: Applied Clinical Trials
- Featured Article
Richard Young, Chief Strategy Officer at CluePoints, shares insights on AI and risk-based quality management (RBQM)...
Source: The Clinical Trial Vanguard
- Featured Article
The pharmaceutical industry is poised for a transformative evolution by 2025, driven by the possibilities of...
Source: PM360
- Featured Article
Central monitoring is highly effective in detecting emerging quality issues in clinical trials, but debate continues...
Source: Applied Clinical Trials
- Featured Article
An essential component of risk-based quality management (RBQM), as detailed in both the ICH E8 (R1)...
Source: Applied Clinical Trials
- Featured Article
The need to boost education, shift culture, and embrace new technologies.
...Source: Applied Clinical Trials
